| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in MicroRNA Therapy for Heart Failure: Clinical Trials, Preclinical Studies, and Controversies
|
Huang, Shengyuan
|
|
|
39 |
1 |
p. 221-232
|
artikel
|
| 2 |
Beneficial Effects of Angiotensin II Receptor Blockers on Mortality in Patients with COVID-19: A Retrospective Study from 2019 to 2020 in China
|
Xu, Ke
|
|
|
39 |
1 |
p. 63-74
|
artikel
|
| 3 |
Beta-blockers and Myocardial Infarction: to β -block or not to β -block
|
Syed, Muhammad Rayan
|
|
|
39 |
1 |
p. 1-2
|
artikel
|
| 4 |
Comparing Renin-Angiotensin-Aldosterone Blockade Regimens for Long-Term Chemotherapy-Related Cardiac Dysfunction: A Network Meta-Analysis
|
Li, Jiaqi
|
|
|
39 |
1 |
p. 171-186
|
artikel
|
| 5 |
Dexmedetomidine Alleviates Abdominal Aortic Aneurysm by Activating Autophagy Via AMPK/mTOR Pathway
|
Yu, Qi
|
|
|
39 |
1 |
p. 33-42
|
artikel
|
| 6 |
Effect of Intensive Lipid-Lowering Therapy on Coronary Plaque Stabilization Derived from Optical Coherence Tomography: a Meta-analysis and Meta-regression
|
Liu, Sen
|
|
|
39 |
1 |
p. 119-132
|
artikel
|
| 7 |
Effects of Dapagliflozin on Myocardial Gene Expression in BTBR Mice with Type 2 Diabetes
|
Ryaboshapkina, Maria
|
|
|
39 |
1 |
p. 43-61
|
artikel
|
| 8 |
Effects of Rhythm Control for Atrial Fibrillation on Cardiac Remodeling and Valvular Regurgitation in Patients with Heart Failure
|
Si, Jinping
|
|
|
39 |
1 |
p. 85-96
|
artikel
|
| 9 |
Enhancing Glucose Uptake as a Means to Protect the Heart During Cardiopulmonary Bypass or Ischemia–Reperfusion Injury
|
Moran, Tyler B.
|
|
|
39 |
1 |
p. 15-16
|
artikel
|
| 10 |
Evaluation of the Efficacy of Sacubitril/Valsartan on Radiofrequency Ablation in Patients with Hypertension and Persistent Atrial Fibrillation
|
Zang, Xiaobiao
|
|
|
39 |
1 |
p. 97-106
|
artikel
|
| 11 |
Exercise Prevents Glucocorticoid-Induced Myocardial 4-Hydroxynonenal Production
|
Hayta, Umit
|
|
|
39 |
1 |
p. 165-169
|
artikel
|
| 12 |
Gab1 in Cardiovascular Disease: An Insufficiently Explored and Controversial Research Area
|
Jing, Da-Tan
|
|
|
39 |
1 |
p. 5-6
|
artikel
|
| 13 |
Glucagon-Like Peptide-1 Receptor Agonists for Abdominal Aortic Aneurysm?
|
Birnbaum, Yochai
|
|
|
39 |
1 |
p. 13-14
|
artikel
|
| 14 |
International Accolades for GLP-1 Research: Recognizing Pioneers in Diabetes and Obesity Treatment Across Five Prestigious Awards
|
Jin, Tianru
|
|
|
39 |
1 |
p. 9-12
|
artikel
|
| 15 |
Minimal Adherence Threshold to Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation to Reduce the Risk of Thromboembolism and Death: A Nationwide Cohort Study
|
Grymonprez, Maxim
|
|
|
39 |
1 |
p. 107-117
|
artikel
|
| 16 |
Netrin-1 and RGMa: Novel Regulators of Atherosclerosis-Related Diseases
|
Yuan, Xiaofan
|
|
|
39 |
1 |
p. 211-219
|
artikel
|
| 17 |
New Evidence on Diclofenac: Implications for Cardiovascular Safety
|
Ullah, Mohammad Saad
|
|
|
39 |
1 |
p. 3-4
|
artikel
|
| 18 |
PDHA1 Alleviates Myocardial Ischemia-Reperfusion Injury by Improving Myocardial Insulin Resistance During Cardiopulmonary Bypass Surgery in Rats
|
Chen, Kai-Yuan
|
|
|
39 |
1 |
p. 17-31
|
artikel
|
| 19 |
Pharmacodynamic Drug-Drug Interactions and Bleeding Outcomes in Patients with Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants: a Nationwide Cohort Study
|
Grymonprez, Maxim
|
|
|
39 |
1 |
p. 133-143
|
artikel
|
| 20 |
Rationale and Design of Prospective, Multicenter, Double-Arm Clinical Trial to Investigate the Efficacy of Tofogliflozin on Left Ventricular Diastolic Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus (TOP-HFPEF Trial)
|
Ito, Shin
|
|
|
39 |
1 |
p. 145-154
|
artikel
|
| 21 |
Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes
|
Pérez, Maeve Soto
|
|
|
39 |
1 |
p. 155-164
|
artikel
|
| 22 |
Sacubitril/Valsartan in Dialysis Patients: Update on Current Perspectives
|
Spatola, Leonardo
|
|
|
39 |
1 |
p. 187-193
|
artikel
|
| 23 |
The Role of CTRP5 in Cardiovascular Disease: Friend or Foe?
|
Chen, Yang
|
|
|
39 |
1 |
p. 7-8
|
artikel
|
| 24 |
The Role of P53 in Myocardial Ischemia-Reperfusion Injury
|
Zhu, Xi-zi
|
|
|
39 |
1 |
p. 195-209
|
artikel
|
| 25 |
US Population Eligibility and Estimated Impact of Semaglutide Treatment on Obesity Prevalence and Cardiovascular Disease Events
|
Wong, Nathan D.
|
|
|
39 |
1 |
p. 75-84
|
artikel
|
Tijdschrift beschrijving